CVS, Express Scripts Beat Forecasts, Growth In Doubt
CVS Caremark (CVS), the dominant U.S. drugstore chain, and its pharmacy benefits partner Express Scripts (ESRX) both reported third-quarter profit that topped Wall Street's outlook. Shares of both companies fell early Tuesday, with Express Scripts plunging as much as 17% early after it said late Monday that analyst forecasts for the current quarter are "overly aggressive," casting a cloud on the pharmacy sector. CVS' revenue climbed to $30.23
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here